An acellular pertussis vaccine in healthy adults: safety and immunogenicity

By Rothstein E.P.   Anderson E.L.   Decker M.D.   Poland G.A.   Reisinger K.S.   Blatter M.M.   Jacobson R.M.   Mink C.M.   Gennevois D.   Izu A.E.   Sinangil F.   Langenberg A.G.M.  

Vaccine, Vol. 17, Iss. 23, 1999-08 ,pp. : 2999-3006

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers

By Drabick J.J.   Brandt B.L.   Moran E.E.   Saunders N.B.   Shoemaker D.R.   Zollinger W.D.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 160-172

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a combined hepatitis A and B vaccine in healthy young adults

By Knoll A.   Hottentrager B.   Kainz J.   Bretschneider B.   Jilg W.  

Vaccine, Vol. 18, Iss. 19, 2000-04 ,pp. : 2029-2032

Elsevier

Access to resources Recommend Favorite

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults

By Leroux-Roels G.   Desombere I.   De Tollenaere G.   Petit M.-A.   Desmons P.   Hauser P.   Delem A.   De Grave D.   Safary A.  

Vaccine, Vol. 15, Iss. 16, 1997-11 ,pp. : 1724-1731

Elsevier

Access to resources Recommend Favorite

Immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccine in healthy children and in children at increased risk of pneumococcal infection

By Hoan-Jong L.   Jin-Han K.   Henrichsen J.   Konradsen H.B.   Seong-Hee J.   Hee-Young S.   Hyo-Seop A.   Yong C.   Hessel L.   Sung-Woo N.  

Vaccine, Vol. 13, Iss. 16, 1995-11 ,pp. : 1533-1538

Elsevier

Access to resources Recommend Favorite